Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TLV/REKA stock hub

TLV/REKA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TLV/REKAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

126.5M

Tel Aviv Stock Exchange

Market data

Price

Recent price action with selectable time range.

TLV/REKATLV/REKA

—

Loading chart…

In the news

Latest news · TLV/REKA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-11.8

P25 n/aP50 n/aP75 n/a

ROIC-2.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TLV/REKA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

ILS

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	IL
Employees	390
Employees Change	-31%
Employees Change Percent	-7.36
Enterprise value	ILA 254.5M
Exchange	Tel Aviv Stock Exchange
Financial currency	ILS
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	IL0010810096
Last refreshed	2026-05-10
Market cap	ILA 126.5M
Price	ILA 1,108
Price currency	ILA
Rev Per Employee	771,766.67x
Sector	Healthcare
Sic	2834
Symbol	tlv/REKA
Website	https://www.rekah.co.il

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-14.29%
EV Earnings	-14.08x
EV/EBITDA	10.95x
EV/FCF	42.97x
EV/Sales	0.85x
FCF yield	4.68%
P/B ratio	0.88x
P/S ratio	0.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-2.41%
EBITDA Margin	5.1%
FCF margin	1.97%
Gross margin	23.11%
Gross Profit	ILA 69.6M
Gross Profit Growth	-3.31%
Gross Profit Growth Q	-16.04%
Gross Profit Growth3 Y	-4.03%
Gross Profit Growth5 Y	0.27%
Net Income	ILA -18.1M
Net Income Growth Years	0%
Pretax Margin	-3.72%
Profit Margin	-6%
Profit Per Employee	ILA -46,344
ROA	-1.04
Roa5y	0.42
ROCE	-2.67
ROE	-11.81
Roe5y	-1.91
ROIC	-2.62
Roic5y	-4.82

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.29%
Cagr15y	-2.24%
Cagr1y	-9.93%
Cagr20y	-1.5%
Cagr3y	-11.73%
Cagr5y	-12.66%
Div CAGR10	0%
Div CAGR5	0%
EPS Growth Years	0
FCF Growth	-66.82%
FCF Growth Q	-73.23%
FCF Growth3 Y	-43.05%
OCF Growth	-51.21%
OCF Growth Q	-60.45%
OCF Growth10 Y	8.35%
OCF Growth3 Y	-30.76%
OCF Growth5 Y	2.79%
Revenue Growth	-6.44x
Revenue Growth Q	0.98x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	0.97x
Revenue Growth5 Y	2.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ILA 0.69
Assets	ILA 423.7M
Cash	ILA 4.4M
Current Assets	ILA 232.7M
Current Liabilities	ILA 151.9M
Debt	ILA 132.4M
Debt EBITDA	ILA 5.67
Debt Equity	ILA 0.92
Debt FCF	ILA 22.35
Equity	ILA 144.2M
Interest Coverage	-1.13
Liabilities	ILA 279.5M
Long Term Assets	ILA 191M
Long Term Liabilities	ILA 127.6M
Net Cash	ILA -128M
Net Cash By Market Cap	ILA -101
Net Debt EBITDA	ILA 8.34
Net Debt Equity	ILA 0.89
Net Debt FCF	ILA 21.61
Tangible Book Value	ILA 87.9M
Tangible Book Value Per Share	ILA 7.7
WACC	4.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.53
Inventory Turnover	2.67
Net Working Capital	ILA 109.3M
Quick ratio	0.92
Working Capital	ILA 80.8M
Working Capital Turnover	ILA 3.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend per share	ILA 0
Last Dividend	ILA 0.87

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-28.43%
1Y total return	-9.92%
200-day SMA	1,176.6
3Y total return	-31.22%
50-day SMA	1,192.5
50-day SMA vs 200-day SMA	50over200
5Y total return	-49.16%
All Time High	35,500
All Time High Change	-96.88%
All Time High Date	1996-08-26
All Time Low	291
All Time Low Change	280.76%
All Time Low Date	1997-11-24
ATR	54.83
Beta	0.14
Beta1y	0.03
Beta2y	0.15
Ch YTD	1.28
High	1,149
High52	1,397
High52 Date	2025-05-20
High52ch	-20.69%
Low	1,082
Low52	1,044
Low52 Date	2025-09-21
Low52ch	6.13%
Ma50ch	-7.09%
Price vs 200-day SMA	-5.83%
RSI	37.28
RSI Monthly	39.48
RSI Weekly	35.36
Sharpe ratio	-0.08x
Sortino ratio	0.06
Tr YTD	1.28
Tr15y	-28.79%
Tr1m	-8.51%
Tr1w	-2.46%
Tr3m	-10.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA -7.2M
Operating margin	-2.41

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,870,944%
Net Borrowing	-7,201,000
Shares Insiders	40.54%
Shares Institutions	0.57%
Shares Out	11,414,636
Shares Qo Q	2.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ILA 5.9M
Average Volume	2,299.55x
Bv Per Share	12.63
CAPEX	ILA -7M
Ch10y	-31.14
Ch15y	-31.48
Ch1m	-8.51
Ch1w	-2.46
Ch1y	-9.92
Ch20y	-30.75
Ch3m	-10.36
Ch3y	-31.22
Ch5y	-51.08
Ch6m	-4.57
Change	0.64%
Change From Open	0.64
Close	1,101
Days Gap	0
Depreciation Amortization	22,589,000
Dollar Volume	2,217,108
Earnings Date	2026-05-29
EBIT	ILA -7.2M
EBITDA	ILA 15.3M
EPS	ILA -1.58
F Score	5
FCF	ILA 5.9M
FCF EV Yield	2.33x
FCF Per Share	ILA 0.52
Financing CF	-9,368,000
Fiscal Year End	December
Founded	1,947
Goodwill	35,143,000
Income Tax	ILA 6.9M
Investing CF	-6,286,000
Is Primary Listing	1
Last Earnings Date	2025-11-27
Last Report Date	2025-12-31
Ma150	1,171.8
Ma150ch	-5.45%
Ma20	1,161.4
Ma20ch	-4.6%
Net CF	-2,692,000
Next Earnings Date	2026-05-29
Open	1,101
P FCF Ratio	21.35
P OCF Ratio	9.77
Position In Range	38.81
Ppne	126,457,000
Price Date	2026-05-08
Price EBITDA	ILA 8.24
Ptbv Ratio	1.44
Relative Volume	0.83x
Revenue	300,989,000x
SBC By Revenue	0.01x
Share Based Comp	38,000
Tax By Revenue	2.28x
Tr20y	-26.13%
Tr6m	-4.57%
Volume	2,001
Z Score	1.2

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TLV/REKA pay a dividend?

Capital-return profile for this ticker.

Performance

TLV/REKA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TLV/REKA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.6%

Share of float held by funds and institutions

Insider ownership

+40.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TLV/REKA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.3

Neutral momentum band

Price vs 200-day MA

-5.8%

50/200-day relationship not available

Beta (5Y)

0.14

Less volatile than the market

Sharpe ratio

-0.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TLV/REKA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/REKA stock rating?

tlv/REKA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/REKA analysis?

The full report lives at /stocks/tlv/REKA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/REKA?

The latest report frames tlv/REKA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/REKA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.